antimycin a has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Ding, X; Hao, S; Jiang, B; Liu, C; Luo, T; Yin, Q; Zhang, Y | 1 |
| Bulabois, CE; Cahn, JY; Carras, S; Carré, M; Courby, S; Faure, P; Garrel, C; Gressin, R; Leer-Florin, AM; Mariette, C; Molina, L; Mondet, J; Mossuz, P; Park, S; Presti, CL; Skaare, K; Socoro-Yuste, N; Thiebaut, A | 1 |
2 other study(ies) available for antimycin a and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Inhibition of mitochondrial complex III induces differentiation in acute myeloid leukemia.
Topics: Antimycin A; Biphenyl Compounds; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dihydroorotate Dehydrogenase; Electron Transport Complex III; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Oxidoreductases Acting on CH-CH Group Donors | 2021 |
Adult patients with
Topics: Adult; Aged; Antimycin A; Antioxidants; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lipid Peroxidation; Male; Middle Aged; Mitochondria; NADPH Oxidases; Onium Compounds; Oxidation-Reduction; Prognosis; Proportional Hazards Models; Prospective Studies; Reactive Oxygen Species; Rotenone; Tetradecanoylphorbol Acetate; Translocation, Genetic | 2019 |